Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06967129 · ClinicalTrials.gov registry record · NA
Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 281
- Enrollment target
NCT06967129 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 281 participants.
The verdict
NCT06967129, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 281 participants
- Enrollment target
Study Summary
This is a prospective, multi-site, dispensing, randomized, controlled, double-masked, bilateral wear, 2x2 crossover study to evaluate the safety and effectiveness of the test lens.
Interventions
- DEVICE Investigational daily disposable, soft, toric lenses manufactured on 4th Generation Technology (4GT) lines with extended mini-stack hydration using propylene glycol (PG) as the hydration solvent.
- DEVICE ACUVUE® Oasys 1-Day for Astigmatism (AO1DfA) soft contact lenses manufactured on 3rd Generation Technology (3GT) legacy lines using isopropyl alcohol (IPA) as the hydration solvent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2025-04-25 |
| Est. Completion | 2025-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06967129
The ClinicalTrials.gov registry entry for NCT06967129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational daily disposable, soft, toric lenses manufactured on 4th Generation Technology (4GT) lines with extended mini-stack hydration using propylene glycol (PG) as the hydration solvent. is the first listed.
NCT06967129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06967129 about?
NCT06967129 is a clinical study titled "Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process". This is a prospective, multi-site, dispensing, randomized, controlled, double-masked, bilateral wear, 2x2 crossover study to evaluate the safety and effectiveness of the test lens.
What is the current status of trial NCT06967129?
This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2025-04-25. Estimated completion is 2025-07-14.
What interventions are being tested in trial NCT06967129?
The interventions under investigation include: Investigational daily disposable, soft, toric lenses manufactured on 4th Generation Technology (4GT) lines with extended mini-stack hydration using propylene glycol (PG) as the hydration solvent. (DEVICE), ACUVUE® Oasys 1-Day for Astigmatism (AO1DfA) soft contact lenses manufactured on 3rd Generation Technology (3GT) legacy lines using isopropyl alcohol (IPA) as the hydration solvent. (DEVICE).
Who is sponsoring clinical trial NCT06967129?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.